TrialMatchReviewed by practicing endocrinologists.
Every trial in our database is vetted for safety profile, IRB approval status, and patient eligibility clarity before it appears in your results.
Dr. Priya Nair, MD
Endocrinologist
Johns Hopkins Diabetes Center
"Most of my Type 2 patients don't realize a trial could mean earlier access to treatments that aren't available yet — at no cost to them."
Dr. Marcus Webb, MD, PhD
Clinical Research Director
UCSF Diabetes Research Center
"The enrollment process has changed dramatically. Screening-to-first-visit now averages fourteen days for most outpatient studies."
Dr. Sandra Okonkwo, MD
Maternal-Fetal Medicine
Northwestern Memorial Hospital
"Gestational diabetes trials are chronically under-enrolled. The research gap is real, and participation directly improves future care."
What do the phases mean?
Your endocrinologist said "maybe a trial" — here's what that actually involves, without the jargon.
Safety First
Small groups of 20–80 participants. Researchers test safety, dosage, and side effects for the first time in humans.
20–80 people
6–12 months
Highest ($300–500/visit)
Does It Work?
Expanded to 100–300 participants. The treatment is tested for effectiveness and further safety evaluation.
100–300 people
1–2 years
Moderate ($150–300/visit)
Comparing Options
Large trials with 1,000–3,000+ participants compared against current standard treatments. Most common phase available.
1,000–3,000+
2–4 years
Standard ($100–200/visit)
Post-Approval
After FDA approval. Ongoing monitoring of long-term effects in the general population. Lowest risk, most flexible.
Thousands
Ongoing
Varies ($50–150/visit)
From search to enrolled: 14 days.
This is the actual timeline of a 58-year-old Type 2 patient from Chicago who enrolled in a Phase 3 GLP-1 study in February 2026.
Matched via TrialMatch
Anonymous estimator returns 6 eligible trials within 90 seconds.
Screening call with coordinator
15-minute phone call. Coordinator reviews your medical history.
Medical record review
Site requests 2 years of lab records. Most clinics fax same day.
In-person eligibility visit
Physical exam, bloodwork, EKG. Takes about 2 hours.
Consent and enrollment
Review informed consent. No pressure — you can leave at any time.
First study visit
Enrolled. First treatment or placebo administered per protocol.
Questions you're afraid to ask.
Answered by the physicians on our advisory board — directly, without hedging.
Trials are closer than you think.
312 active diabetes trial sites across 48 states. Many offer remote screening and telehealth check-ins — you don't always need to travel.
847
Active trials
312
Trial sites
48
States covered
14 days
Avg. to enroll
Questions to ask your doctor
about clinical trials.
A one-page PDF you can print or pull up on your phone during your next appointment. Written by our physician advisory board so you don't have to search for the right words.
Doctor Conversation Guide
1 page · PDF · Free
- 1
Am I a candidate for any current diabetes trials?
- 2
Would participating affect my current medication plan?
- 3
What would the time commitment look like for me?
- 4
How would my data be protected?
- 5
Can I withdraw without affecting our doctor-patient relationship?
- 6
Would you co-manage my care with the trial team?
Get the guide
Enter your email and we'll send the PDF instantly — plus your trial matches if you've already run the estimator.
No spam. Unsubscribe anytime. We don't sell medical data — ever.
HIPAA Compliant
No data sold
IRB Reviewed